Johnson & Johnson (JNJ) Short-term Investments (2009 - 2026)

Johnson & Johnson has reported Short-term Investments for 18 years, with the latest figure at $336.0 million in Q2 2026.

• Quarterly Short-term Investments rose 10.89% year-over-year to $336.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $336.0 million (up 10.89% YoY) and the FY2025 annual result came in at $393.0 million, down 5.76% from the prior year.
• Short-term Investments eased to $336.0 million in Q2 2026 per JNJ's latest filing, from $363.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $22.7 billion in Q4 2022 and troughed at $303.0 million in Q2 2025.
• A 5-year average of $5.9 billion and a median of $745.0 million in 2024 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2022 and 2024: Short-term Investments surged 96.69% in 2022, then sank 91.85% in 2024.
• Over 5 years, Short-term Investments stood at $22.7 billion in 2022, then slumped by 95.3% to $1.1 billion in 2023, then sank by 60.96% to $417.0 million in 2024, then retreated by 5.76% to $393.0 million in 2025, then fell by 14.5% to $336.0 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $336.0 million, $363.0 million, and $393.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.